All News

The latest updates in non–small cell lung cancer (NSCLC) cover recommendations for diagnostics, staging, when to use biomarker testing, sequencing of therapeutic options, and the addition of new treatments.

Virtual care not only means saved time and costs for employees, but improvements to employers' bottom lines, through more proactive management of health concerns, notes UCM Digital Health CEO and co-founder Keith Algozzine.

In this column, a health insurance executive discusses 2 ways to address rising inflation, including moving past the traditional fee-for-service payment model.

With greater attention being paid to the heterogenous patient population, researchers questioned whether this has resulted in a more diverse group of patients included in Parkinson disease (PD) studies in the Netherlands.

Vaccination was shown to lower risk of developing severe COVID-19 in both variants, with the largest difference in risk observed in patients aged 40 to 59 years.

A novel test developed at Cedars-Sinai Medical Center was able to detect and characterize even microscopic amounts of prostate cancers and could potentially help individualize treatment in the clinical setting.

A study attempted to see how symptoms affect quality of life after adjusting for confounding factors.

Jeremy Abramson, MD, director of the Jon and Jo Ann Hagler Center for Lymphoma at the Massachusetts General Hospital Cancer Center, shared his take on the potential benefits of chimeric antigen receptor (CAR) T-cell therapy in earlier lines of treatment.

Gregory Vidal, MD, PhD, director of Clinical Research at West Cancer Center & Research Institute, spoke about community-level discussions within diversity, equity, and inclusion to be addressed at the 8th Annual West Oncology Conference.

Five leading academic cancer centers are assessing the feasibility of implementing the Health Equity Report Card pilot project as a tool that can both meaningfully and feasibly measure and report on equitable care practices.

Sharon Gill, MBA, chief visionary officer, Total Health, reviewed the agenda and key topics to be presented at the West Oncology Conference in Memphis, Tennessee, which takes place February 4-5, 2023.

Having models like these that produce more plausible results are crucial for decision-making in an era of targeted treatments that often come with immature data, argued researchers of their findings for minimal residual disease (MRD) in newly diagnosed multiple myeloma (NDMM).

The bill could have saved CMS about $26.5 billion had it been in place from 2018-2020, the study showed.

Approximately 70% of veterans with drug-resistant epilepsy reported diagnosis of at least 1 psychiatric condition, with female patients showing a higher prevalence than male patients.

The approval is based on results from the phase 3 TROPiCS-02 trial demonstrating overall and progression survival benefits with sacituzumab govitecan compared with physician’s choice of single-agent chemotherapy.

Despite overall improvements in survival outcomes in recent decades, disparities in survival outcomes persist among children and young adults with acute lymphocytic leukemia (ALL) across racial and ethnic groups.

CDC warns against EzriCare Artificial Tears, which were recalled by the manufacturer; certain weight loss drugs not covered by most payers; Mississippi's Republican governor denies being privately in support of Medicaid expansion.

At the start of the COVID-19 pandemic, high levels of distress, overwhelm with daily problems, and unmet psychosocial information needs decreased caregiver-reported health-related quality of life in children with rare diseases.

Younger patients with type 1 diabetes (T1D) and comorbid post-traumatic stress disorder (PTSD) faced the strongest negative impact on certain T1D outcomes compared with patients without PTSD or general mental comorbidities.

Paul G. Alexander, MD, MPH, executive vice president and chief health equity and transformation officer, RWJBarnabas Health, discusses how community partnerships helped ameliorate disparities in health care access and accessibility, as well as food and travel insecurities amid the COVID-19 pandemic.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The study suggests there is measurable amount of microbiome within the soft tissue sarcoma tumor environment, which was previously thought to be sterile.

Amy Crawford-Faucher, MD, vice chair of the Primary Care Institute and Department of Family Medicine at Allegheny Health Network, discussed treatment of respiratory syncytial virus (RSV) without a vaccine and what a future vaccine could mean for older adults.

With atopic dermatitis (AD) prevalence increasing around the world, primarily in developing countries, investigators evaluated the potential for pollution to have an impact on development of the chronic skin condition among an adult population.

Edward Partridge, MD, chief medical officer of Guideway Care, spoke on his organization’s 25-year history in addressing cancer disparities and the crucial role that care navigators/guides have in achieving value-based care within oncology.

A new study aimed to assess the quality and reliability of videos uploaded to YouTube that provide information around spinal muscular atrophy (SMA).

Merck & Co. and Eli Lilly & Co. report sales loss for COVID-19 treatments; Republican state attorneys general tell CVS and Walgreens that mailing mifepristone might break the law; exposure to air pollution over time is associated with a rise in incidence of depression and anxiety.

A DNA sequencing analysis associated Q192R polymorphism in the paraoxonase 1 gene with female infertility in Saudi women.